![Peter Slover](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Slover
Finanzdirektor/CFO bei
CONTINEUM THERAPEUTICS, INC.
Vermögen: 45 084 $ am 31.05.2026
Profil
Peter T.
Slover is Chief Financial & Accounting Officer at Contineum Therapeutics, Inc. since 2020.
Formerly, Mr. Slover was Chief Financial & Accounting Officer at Sophiris Bio, Inc. from 2013 to 2020.
From 2009 to 2010, served as Chief Financial Officer, CAO & SVP-Operations at Anadys Pharmaceuticals, Inc. Worked as an Auditor at KPMG LLP from 1997 to 2004.
Completed undergraduate education at Shippensburg University of Pennsylvania in 1997.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 17.04.2026 | 3’342 ( 0.01% ) | 45 084 $ | 31.05.2026 |
Aktive Positionen von Peter Slover
| Unternehmen | Position | Beginn |
|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Finanzdirektor/CFO | 01.09.2020 |
Ehemalige bekannte Positionen von Peter Slover
| Unternehmen | Position | Ende |
|---|---|---|
| SOPHIRIS BIO | Finanzdirektor/CFO | 01.05.2020 |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Finanzdirektor/CFO | - |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Corporate Officer/Principal | 01.01.2004 |
Ausbildung von Peter Slover
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
94
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Sophiris Bio, Inc.
 Sophiris Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of urological diseases | Health Technology |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
Shippensburg University of Pennsylvania
 Shippensburg University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pipeline Therapeutics, Inc.
 Pipeline Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel, oral small molecule therapies for neuroscience, inflammation and immunology indications | Health Technology |
